Your session is about to expire
← Back to Search
Long-term opioid recipient for Opioid Abuse (AESOPS-T1 Trial)
N/A
Waitlist Available
Led By Jason N Doctor, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 19-24 months
Awards & highlights
AESOPS-T1 Trial Summary
This trial is testing whether "behavioral insights" can discourage unnecessary opioid prescribing, in an effort to improve the health of persons in the U.S. affected by the opioid epidemic.
Eligible Conditions
- Opioid Abuse
AESOPS-T1 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 19-24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~19-24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Other outcome measures
Morphine
Change in proportion of patients prescribed opioids of > 50 MME/day
AESOPS-T1 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral Intervention ArmExperimental Treatment3 Interventions
Clinicians in clinics randomized to the intervention group will be prompted with an EHR nudge when the prescribing history for the patient falls into one of the following three categories: Opioid naïve, At-risk for long-term use, or Long-term opioid recipient. These EHR-based nudges include elements of accountable justification, defaults and precommitments. Clinicians will also receive web-based guideline education, consisting of an online educational module at the start of the study period. This will include educational clinical content related to the CDC guidelines, the Oregon Pain Guidance document, tapering training and other resources such as Substance Abuse and Mental Health Services Administration (SAMHSA) Medication-Assisted Treatment Physician Locator and the Naloxone Provider Guide.
Group II: ControlActive Control1 Intervention
Clinicians in clinics randomized to the control group will receive web-based guideline education, consisting of an online educational module at the start of the study period. This will include educational clinical content related to the CDC guidelines, the Oregon Pain Guidance document, tapering training and other resources such as Substance Abuse and Mental Health Services Administration (SAMHSA) Medication-Assisted Treatment Physician Locator and the Naloxone Provider Guide.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
At-risk for long-term use, OR
2020
N/A
~560
Long-term opioid recipient
2019
N/A
~600
Opioid Naive, OR
2020
N/A
~560
Find a Location
Who is running the clinical trial?
AltaMed Health ServicesOTHER
7 Previous Clinical Trials
30,646 Total Patients Enrolled
1 Trials studying Opioid Abuse
61 Patients Enrolled for Opioid Abuse
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,595,763 Total Patients Enrolled
1 Trials studying Opioid Abuse
61 Patients Enrolled for Opioid Abuse
Northwestern UniversityOTHER
1,585 Previous Clinical Trials
916,676 Total Patients Enrolled
1 Trials studying Opioid Abuse
61 Patients Enrolled for Opioid Abuse
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment actively seeking participants?
"The clinicaltrial.gov website conveys that this particular trial, which was posted on December 1st 2020 and last updated October 10th 2022, is no longer open to new participants. However, there are still 292 other studies currently recruiting volunteers."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger